Učitavanje...
Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
BACKGROUND: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors (ICIs) in UM have demonstrated response rates lower than those seen in cutaneous melanoma. Despite lower efficacy demons...
Spremljeno u:
| Izdano u: | Ocul Oncol Pathol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8280448/ https://ncbi.nlm.nih.gov/pubmed/34307327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000513336 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|